U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Chapter 4 - Human Drugs
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

Chapter 4 - Human Drugs

Final

Sub Chapter 400 - General

Sub Chapter 410 - Bulk Drugs

Sub Chapter 420 - Compendial /Test Requirements

Sub Chapter 425 - Computerized Drug Processing

Sub Chapter 430 - Labeling and Repackaging

Sub Chapter 440 - 448 - New Drugs

Sub Chapter 450 - 457 - OTC

Sub Chapter 460 - Pharmacy Issues

Sub Chapter 470 - Post Approval Issues

Sub Chapter 480 - Stability/Expiration

Sub Chapter 490 - Validation

 

Sub Chapter 400 - General

Sub Chapter 410 - Bulk Drugs

Sub Chapter 420 - Compendial /Test Requirements

Sub Chapter 425 - Computerized Drug Processing

Sub Chapter 430 - Labeling and Repackaging

Sub Chapter 435 - Medical Gases

Sub Chapter 440 - 448 - New Drugs

Sub Chapter 450 - 457 - OTC

Sub Chapter 460 - Pharmacy Issues

Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

Back to Top